Patients with metabolic syndrome and obesity are more likely to have this disparity, which is characterized by elevated ApoB levels without necessarily elevated LDL-C concentrations [28–30]. The gene discussed is APOB; the disease is obesity due to melanocortin 4 receptor deficiency.